The diverse roles of circular RNAs in cholangiocarcinoma.
1/5 보강
Cholangiocarcinoma (CCA) is a malignant tumor that develops in the extrahepatic bile duct, that is, from the left and right hepatic ducts to the lower end of the common bile duct.
APA
Zhang Y, Xing X, et al. (2025). The diverse roles of circular RNAs in cholangiocarcinoma.. Medical oncology (Northwood, London, England), 42(10), 455. https://doi.org/10.1007/s12032-025-03018-3
MLA
Zhang Y, et al.. "The diverse roles of circular RNAs in cholangiocarcinoma.." Medical oncology (Northwood, London, England), vol. 42, no. 10, 2025, pp. 455.
PMID
40879959
Abstract
Cholangiocarcinoma (CCA) is a malignant tumor that develops in the extrahepatic bile duct, that is, from the left and right hepatic ducts to the lower end of the common bile duct. Because of its indeterminate etiology, difficulties in the diagnosis of early lesions, easy invasion and metastasis and resistance to chemotherapeutic drugs, the trend of mortality rate deterioration of patients with CCA has not been fundamentally reversed. And the molecular mechanisms underlying the development of CCA are not well characterized. Circular RNA (CircRNA) is an endogenous non-coding RNA with a circular structure. Recent studies have found circRNA involved in multiple physiological processes and participated in the proliferation, invasion, metastasis, immunomodulation, angiogenesis, biometabolism, and chemoresistance of many malignancies, including CCA, pancreatic cancer, liver cancer, and gastric cancer. In this review, we summarize what has been published so far to be related to the biogenesis, functions, and characteristics of circRNAs in CCA and the potential clinical prospects.
MeSH Terms
Humans; Cholangiocarcinoma; RNA, Circular; Bile Duct Neoplasms; Biomarkers, Tumor
같은 제1저자의 인용 많은 논문 (5)
- Comment on: "Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition".
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Impact of contrast-enhanced computed tomography surveillance frequency on survival outcomes in patients with stage I-III colorectal cancer: A propensity score-matched retrospective cohort study.
- Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].
- Dietary restriction genes as modulators of breast cancer risk through metabolic pathways.